Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec, Celgene Collaboration Reaches Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec, Celgene Collaboration Reaches Milestone

Resulting in Celgene designating a program and triggering a payment of $ 14M to Evotec

By: Betsy Louda

, Contract Pharma

Evotec AG‘s strategic alliance with Celgene has reached another important scientific achievement, resulting in Celgene designating a program and triggering a $14M milestone payment  to Evotec. 

 
The payment was received by year-end 2018. This scientific achievement was the advancement of a program into the lead optimization stage developed from Evotec’s compound library using its induced pluripotent stem cell (“iPSC”)-based screening platform. This program can be further optimized and progressed towards IND-ready status.  
 
Evotec and Celgene initiated the collaboration in December 2016 to identify disease-modifying treatments for a broad range of neurodegenerative diseases. The collaboration pursues an innovative approach to the discovery and development of novel medicines by leveraging Evotec’s unique human iPSC technology platform, which is one of the largest platforms in the industry.  
 
Dr Cord Dohrmann, chief scientific officer of Evotec, said, “We are very proud of the success achieved in our collaboration with Celgene, which we believe validates our iPSC approach and is a testament to a highly productive collaboration. I would like to congratulate the teams from both companies on the excellent progress and wish them continued success moving forward.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters